An Innovative Journal in the Field of Radiology
Management of Loco-Regional Interventions in HCC
Authors
Abstract
Some patients are more susceptible to HCC (like HBV, Cirrhosis and ). In these patientsscreening imaging (ultrasound) is highly recommended. In positive cases next step would be 4-phasic CT scan or dynamic MRI for confirm diagnosis and also staging. If there are typical signs of HCC (wash in, wash out), biopsy is not necessary in susceptible populations. Gold standard treatment of HCC is surgery (resection or liver transplantation). In thosecases which are not candidate for surgery, Loco-Regional treatments are key players. The mostnoticeable of these are: TACE (Trans Arterial Chemoembolization) and Local Ablations (RF, Microwave, Alcohol injections and ). Site and Size of tumors should be considered in decision forablative techniques. Limitations for RF are 1) tumors more than 3 cm or 2) subcapsular locationor 3) neighboring to large vessels, but there are less limitations in Microwave. TACE is one of thetreatment of choice in cases which are not candidate for surgery or thermal ablations (intermediate stage). There are also some limitations for TACE which the most important one is decompensated cirrhosis (child B8, 9 and C). In this technique there are two factors (ischemia and chemotherapy) attenuating the tumors with synergistic effect. Generally TACE has a palliative situation in the guidelines but could be used as a bridge for curative plan (surgery or liver transplantation) alone or in combination with ablation techniques.
Highlights
Copyright
© 2017, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
Imaging and Imaging-Guided Interventions in the Diagnosis and Management of Hepatocellular Carcinoma (HCC)-Review of Evidence
Ghanaati H, Alavian SM, Jafarian A, Ebrahimi Daryani N, Nassiri-Toosi M, et al. Imaging and Imaging-Guided Interventions in the Diagnosis and Management of Hepatocellular Carcinoma (HCC)-Review of Evidence. I J Radiol. 2012;9(4):. doi: https://doi.org/10.5812/iranjradiol.8242
Safety and Efficacy of Transcatheter Arterial Chemoemboliazation in the Real-Life Management of Unresectable Hepatocellular Carcinoma
Mazioti A, K. Gatselis N, Rountas C, Zachou K, K. Filippiadis D, et al. Safety and Efficacy of Transcatheter Arterial Chemoemboliazation in the Real-Life Management of Unresectable Hepatocellular Carcinoma. Hepat Mon. 2013;13(8):7070. doi: https://doi.org/10.5812/hepatmon.7070
Tailoring of Interventional Procedures for HCC Patients-Review Article
Ghanaati H, Alavian SM, Firouznia K, Abedini MR, Mohammadifard M, et al. Tailoring of Interventional Procedures for HCC Patients-Review Article. I J Radiol. 2010;7(3):e77324. doi:
Recent Advances in Radiofrequency Ablation for the Management of Hepatocellular Carcinoma
Himoto T, Kurokohchi K, Watanabe S, Masaki T. Recent Advances in Radiofrequency Ablation for the Management of Hepatocellular Carcinoma. Hepat Mon. 2012;12(10):5945. doi: https://doi.org/10.5812/hepatmon.5945
Transcatheter Arterial Chemoembolization Therapy for Patients With Unresectable Hepatocellular Carcinoma
Firouznia K, Ghanaati H, Alavian SM, Azadeh P, Nasiri Toosi M, et al. Transcatheter Arterial Chemoembolization Therapy for Patients With Unresectable Hepatocellular Carcinoma. Hepat Mon. 2014;14(12):e25792. doi: https://doi.org/10.5812/hepatmon.25792
- Scopus by DOI: 0
Last Update: 1 week ago
- Scopus by Title: 0
Last Update: 1 week ago
- Scopus by Title (Ref): 0
Last Update: 1 week ago
- CrossRef: 0
Last Update: 6 days ago
- OpenAlex: 0
Last Update: 2 days ago
- OpenCitations: 0
Last Update: 3 days ago